TP53 and prostate carcinoma: Non-cell-specific uptake of p53pAnt has been previously demonstrated by Western blotting of cell lysates and immunostaining by an antibody specific to the p53-derived portion of p53pAnt [25,52], whereas confocal microscopy with a rhodamine B-labeled peptide showed that it accumulates both in the cytosol and the nuclei of two prostate cancer cell lines [52].